A detailed history of Balyasny Asset Management LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Balyasny Asset Management LLC holds 681,421 shares of CNTA stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
681,421
Previous 1,023,122 33.4%
Holding current value
$11.5 Million
Previous $9.24 Million 17.94%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.58 - $16.99 $2.93 Million - $5.81 Million
-341,701 Reduced 33.4%
681,421 $10.9 Million
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $6.18 Million - $9.12 Million
768,676 Added 302.1%
1,023,122 $9.24 Million
Q1 2024

May 13, 2024

BUY
$6.73 - $12.2 $1.71 Million - $3.1 Million
254,446 New
254,446 $2.88 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.59B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.